Literature DB >> 14647414

Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.

Allison E Bonner1, William J Lemon, Theodora R Devereux, Ronald A Lubet, Ming You.   

Abstract

We have performed oligonucleotide array analysis on various murine lung tissues [normal lungs, lung adenomas, and lung adenocarcinomas (ACs)] using Affymetrix U74Av2 GeneChips to examine the complex genetic changes occurring during lung carcinogenesis. Analysis yielded 20 novel genes differentially expressed in both lung adenomas and ACs versus normal lungs, including the tumor suppressor APC2 and the oncogene Ros 1. In addition, 50 genes were found to be differentially expressed in lung adenomas versus lung ACs, including the differentiation factor Hox C6, the oncogene Ets 2, and the Ras nuclear transport factor, nuclear transport factor 2. To understand the potential relationship between genes expressed in murine lung tumors and its relationship to altered gene expression observed during embryogenesis and postnatal development, tissues from embryonic lungs and from lungs of mice up to 4 weeks following birth were examined using Affymetrix U74Av2 GeneChips. From this analysis, approximately 1300 genes were determined to exhibit differential expression in fetal lung versus postnatal lung. When we compared lung adenomas, lung ACs, and normal lung parenchyma, 24 developmentally regulated genes were found aberrantly expressed in lung tumors; these included the cell cycle control factor CDC5, the cellular differentiation factor TEA domain 4, and the proapoptotic factor BNIP 2. Finally, we compared the murine lung tumor gene expression data to the expression of genes in human lung cancer, in order to assess the relevance of murine lung cancer models in the study of human AC formation. When the 17 human lung ACs and six human lung large cell carcinomas were examined, it was found that 13 of the 17 human lung ACs clustered tightly together in a pattern that was different from the remaining four human lung ACs and six large cell carcinomas, which exhibited a different pattern. Interestingly, the mouse lung adenomas appeared similar to 13 clustered ACs, while mouse lung ACs appeared more similar in pattern to the group consisting of four ACs and six large-cell carcinomas (LCCs). Nevertheless, when compared with the combined human ACs, 39 genes with similar expression changes in murine lung tumors and human ACs/LCCs were identified, such as the oncogene-related BCL7B, the cell cycle regulator CDK4, and the proapoptotic Endophilin B1. Overall, we have determined, for the first time, the expression profiles during murine lung tumor progression and have established, at the molecular level, an association between murine lung tumorigenesis and lung development. We have also attempted to compare the expression profiles found in mouse lung cancers and those in human lung ACs.

Entities:  

Mesh:

Year:  2004        PMID: 14647414     DOI: 10.1038/sj.onc.1207234

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Down-regulation of Bax-interacting factor 1 in human pancreatic ductal adenocarcinoma.

Authors:  Domenico Coppola; James Helm; Msoumeh Ghayouri; Mokenge P Malafa; Hong-Gang Wang
Journal:  Pancreas       Date:  2011-04       Impact factor: 3.327

2.  Establishment and characterization of a human large cell lung cancer cell line with neuroendocrine differentiation.

Authors:  Sedigheh Sharifzadeh; S Mohammad Owji; Abdul Mohammad Pezeshki; Zahra Malek-Hoseini; Perikala Vijayananda Kumar; Sied Mohammad Ali Ghayumi; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

3.  Aneuploidy arises at early stages of Apc-driven intestinal tumorigenesis and pinpoints conserved chromosomal loci of allelic imbalance between mouse and human.

Authors:  Paola Alberici; Emma de Pater; Joana Cardoso; Mieke Bevelander; Lia Molenaar; Jos Jonkers; Riccardo Fodde
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 4.  Genomics of lung cancer.

Authors:  Alain C Borczuk; Rebecca L Toonkel; Charles A Powell
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

5.  In vitro toxicological evaluation of ethyl carbamate in human HepG2 cells.

Authors:  Xia Cui; Jiayi Wang; Nannan Qiu; Yongning Wu
Journal:  Toxicol Res (Camb)       Date:  2016-02-08       Impact factor: 3.524

6.  Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis.

Authors:  Kumud R Poudel; Minna Roh-Johnson; Allen Su; Thuong Ho; Haritha Mathsyaraja; Sarah Anderson; William M Grady; Cecilia B Moens; Maralice Conacci-Sorrell; Robert N Eisenman; Jihong Bai
Journal:  Dev Cell       Date:  2018-06-18       Impact factor: 12.270

7.  Alterations in gene expression and DNA methylation during murine and human lung alveolar septation.

Authors:  Alain Cuna; Brian Halloran; Ona Faye-Petersen; David Kelly; David K Crossman; Xiangqin Cui; Kusum Pandit; Naftali Kaminski; Soumyaroop Bhattacharya; Ausaf Ahmad; Thomas J Mariani; Namasivayam Ambalavanan
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

8.  Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells.

Authors:  Carl E Allen; Jianguo Du; Bo Jiang; Qin Huang; Adam J Yakovich; John A Barnard
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

9.  Bax-interacting factor-1 expression in prostate cancer.

Authors:  Domenico Coppola; Cecilia Oliveri; Zena Sayegh; David Boulware; Yoshinori Takahashi; Julio Pow-Sang; Julie Y Djeu; Hong-Gang Wang
Journal:  Clin Genitourin Cancer       Date:  2008-09       Impact factor: 2.872

10.  Prenatal N-acetylcysteine prevents cigarette smoke-induced lung cancer in neonatal mice.

Authors:  Roumen Balansky; Gancho Ganchev; Marietta Iltcheva; Vernon E Steele; Silvio De Flora
Journal:  Carcinogenesis       Date:  2009-05-20       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.